Related Experiment Videos
[Mediastinal diffuse large-cell lymphoma with sclerosis diagnosed by needle biopsy]
S Yamaguchi1, M Sawamura, T Matsushima
1Third Department of Internal Medicine, Gunma University School of Medicine.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|February 1, 1993
Summary
Mediastinal diffuse large-cell lymphoma with sclerosis, a rare cancer, can be diagnosed from small needle biopsy samples. This diagnosis aids in effective combination chemotherapy treatment.
Area of Science:
- Oncology
- Pathology
- Medical Imaging
Background:
- Anterior mediastinal masses can present diagnostic challenges.
- Diffuse large-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
- Sclerosis is a feature that can complicate the histological diagnosis of lymphomas.
Observation:
- A 28-year-old woman presented with cough and an anterior mediastinal mass on CT scan.
- Transcutaneous needle biopsy revealed tumor cells positive for CD20 and CD45, with JH rearrangement.
- Histopathology showed tumor cell infiltration and compartmentalizing fibrosis.
Findings:
- The patient was diagnosed with mediastinal diffuse large-cell lymphoma with sclerosis.
- Immunohistochemistry (CD20, CD45) and molecular analysis (JH rearrangement) confirmed the diagnosis.
- The tumor demonstrated a positive response to combination chemotherapy.
Implications:
- Transcutaneous needle biopsy is a viable method for diagnosing mediastinal diffuse large-cell lymphoma with sclerosis.
- Early and accurate diagnosis facilitates timely and effective therapeutic interventions.
- This case highlights the importance of integrating imaging, histology, and molecular pathology for complex lymphoma diagnoses.